Motixafortide+G-CSF Clinical Trials

1 actively recruiting trial

Also known as: BL-8040+G-CSF

Pipeline

Phase 3: 1

Top Sponsors

Guangzhou Gloria Biosciences Co., Ltd.1

Indications

Multiple Myeloma1
Cancer1

Other1 trial

Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.